-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MaGLuGc0EMYZBiEXY/S0WFka68DwqlnlpToD2+OQPPtfY5pCxKxc6Mxo4ibYTxu+ qwVL8MtWRTVj5TzC//lcqw== 0000950144-99-005856.txt : 19990514 0000950144-99-005856.hdr.sgml : 19990514 ACCESSION NUMBER: 0000950144-99-005856 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990513 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CV THERAPEUTICS INC CENTRAL INDEX KEY: 0000921506 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 431570294 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-47551 FILM NUMBER: 99620403 BUSINESS ADDRESS: STREET 1: 3172 PORTER DR CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6508120585 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: QUINTILES TRANSNATIONAL CORP CENTRAL INDEX KEY: 0000919623 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561714315 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 4709 CREEKSTONE DR STREET 2: RIVERBIRCH BLDG STE 200 CITY: DURHAM STATE: NC ZIP: 27703-8411 BUSINESS PHONE: 9199982000 MAIL ADDRESS: STREET 1: 4709 CREEKSTONE DR STREET 2: STE 300 CITY: DURHAM STATE: NC ZIP: 27703-8411 SC 13G 1 CV THERAPEUTICS/QUINTILES TRANSNATIONAL 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. __) * CV THERAPEUTICS, INC. --------------------- (Name of Issuer) COMMON STOCK, $.001 PAR VALUE ------------------------------ (Title of Class of Securities) 126667 10 4 -------------- (CUSIP Number) May 5, 1999 ----------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 5 Pages 2 - --------------------- ----------------- CUSIP No. 126667 10 4 Schedule 13G Page 2 of 5 Pages - --------------------- ----------------- - -------------------------------------------------------------------------------- 1) NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only). Quintiles Transnational Corp. I.R.S. Employer Identification No.: 56-1714315 - -------------------------------------------------------------------------------- 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] NOT APPLICABLE - -------------------------------------------------------------------------------- 3) SEC USE ONLY - -------------------------------------------------------------------------------- 4) CITIZENSHIP OR PLACE OF ORGANIZATION North Carolina - -------------------------------------------------------------------------------- 5) SOLE VOTING POWER NUMBER OF 1,043,705 SHARES ----------------------------------------------------- BENEFICIALLY 6) SHARED VOTING POWER OWNED BY -0- EACH ----------------------------------------------------- REPORTING 7) SOLE DISPOSITIVE POWER PERSON 1,043,705 WITH: ----------------------------------------------------- 8) SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,043,705 - -------------------------------------------------------------------------------- 10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) NOT APPLICABLE [ ] - -------------------------------------------------------------------------------- 11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.49% - -------------------------------------------------------------------------------- 12) TYPE OF REPORTING PERSON (See Instructions) CO 3 - --------------------- ----------------- CUSIP No. 126667 10 4 Schedule 13G Page 3 of 5 Pages - --------------------- ----------------- Item 1. (a) Name of Issuer CV Therapeutics, Inc. (b) Address of Issuer's Principal Executive Offices 3172 Porter Drive Palo Alto, California 94304 Item 2. (a) Name of Person Filing Quintiles Transnational Corp. (b) Address of Principal Business Office or, if none, Residence 4709 Creekstone Drive Riverbirch Building, Suite 200 Durham, North Carolina 27703 (c) Citizenship: North Carolina (d) Title of Class of Securities Common stock, par value $.001 per share (e) CUSIP Number 126667 10 4 Item 3. Not applicable. Item 4. Ownership (a) Amount Beneficially Owned: As of May 5, 1999, the reporting person beneficially owned 1,043,705 shares of Common Stock of CV Therapeutics, Inc. 4 - --------------------- ----------------- CUSIP No. 126667 10 4 Schedule 13G Page 4 of 5 Pages - --------------------- ----------------- (b) Percent of Class: Such 1,043,705 shares of Common Stock are 8.49% of the 12,291,960 shares of Common Stock outstanding as of May 5, 1999, as reported by CV Therapeutics, Inc. to the reporting person. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,043,705 (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: 1,043,705 (iv) shared power to dispose or to direct the disposition of: -0-
Item 5. Ownership of Five Percent or Less of a Class Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 5 - --------------------- ----------------- CUSIP No. 126667 10 4 Schedule 13G Page 5 of 5 Pages - --------------------- ----------------- Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: May 11, 1999 Signature: Quintiles Transnational Corp. By: /s/ John Russell -------------------------------------- Name: John Russell Title: Vice President and General Counsel -----END PRIVACY-ENHANCED MESSAGE-----